Aurinia Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Edmonton, Alberta, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
Aurinia Pharmaceuticals Inc. has filed 613 SEC EDGAR filings since 28 Feb 2014

SEC filing history

Showing 51-75 of 205 matching filings.

Per page
25
Current page
3
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
18 Jul 2019
Reporting date
18 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
27 Jun 2019
Reporting date
26 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
21 Jun 2019
Reporting date
19 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
19 Jun 2019
Reporting date
19 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
07 Jun 2019
Reporting date
07 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
31 May 2019
Reporting date
31 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
31 May 2019
Reporting date
29 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
14 May 2019
Reporting date
31 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
14 May 2019
Reporting date
14 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
10 May 2019
Reporting date
10 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
30 Apr 2019
Reporting date
30 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
11 Apr 2019
Reporting date
11 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
19 Mar 2019
Reporting date
19 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
14 Mar 2019
Reporting date
14 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
27 Feb 2019
Reporting date
27 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
25 Feb 2019
Reporting date
25 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
22 Jan 2019
Reporting date
22 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
30 Nov 2018
Reporting date
30 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
08 Nov 2018
Reporting date
30 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
08 Nov 2018
Reporting date
08 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
25 Sep 2018
Reporting date
25 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
09 Aug 2018
Reporting date
30 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
09 Aug 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
11 Jul 2018
Reporting date
11 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
25 Jun 2018
Reporting date
25 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .